Exploiting Temozolomide-Induced Hypermutation With Pembrolizumab in a Refractory High-Grade Neuroendocrine Neoplasm: A Proof-of-Concept Case
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
2
Citations
NaN
KQI